Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Cisplatin Neoadjuvant and Adjuvant Therapy in Stage III NSCLC
NCT00172380Phase 2Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Feb 2005
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of docetaxel and cisplatin in non-small cell lung cancer (NSCLC), sponsored by National Taiwan University Hospital. Primary endpoint: Overall Response Rate. Started Feb 2005; status: completed.
02
Drugs
docetaxelcisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00172380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00172380.